{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29
  ],
  "modelUsed": "claude-opus-4-5",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "Tirzepatide 5 mg",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive tirzepatide 5 mg once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      },
      {
        "id": "arm_2",
        "name": "Tirzepatide 10 mg",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive tirzepatide 10 mg once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      },
      {
        "id": "arm_3",
        "name": "Tirzepatide 15 mg",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive tirzepatide 15 mg once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      },
      {
        "id": "arm_4",
        "name": "Placebo",
        "type": {
          "code": "Placebo Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Placebo Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Participants receive placebo once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_1",
        "epochId": "epoch_4",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_1",
        "epochId": "epoch_5",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_9",
        "armId": "arm_2",
        "epochId": "epoch_4",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_10",
        "armId": "arm_2",
        "epochId": "epoch_5",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_11",
        "armId": "arm_3",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_12",
        "armId": "arm_3",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_13",
        "armId": "arm_3",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_14",
        "armId": "arm_3",
        "epochId": "epoch_4",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_15",
        "armId": "arm_3",
        "epochId": "epoch_5",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_16",
        "armId": "arm_4",
        "epochId": "epoch_1",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_17",
        "armId": "arm_4",
        "epochId": "epoch_2",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_18",
        "armId": "arm_4",
        "epochId": "epoch_3",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_19",
        "armId": "arm_4",
        "epochId": "epoch_4",
        "elementIds": [],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_20",
        "armId": "arm_4",
        "epochId": "epoch_5",
        "elementIds": [],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [
      {
        "id": "cohort_1",
        "name": "Participants without prediabetes",
        "instanceType": "StudyCohort",
        "characteristic": "Participants without prediabetes at randomization who complete 72 weeks of treatment"
      },
      {
        "id": "cohort_2",
        "name": "Participants with prediabetes",
        "instanceType": "StudyCohort",
        "characteristic": "Participants with prediabetes at randomization who continue for additional 104 weeks (total 176 weeks) to assess progression to T2DM"
      }
    ],
    "summary": {
      "armCount": 4,
      "cellCount": 20,
      "cohortCount": 2
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Double Blind",
        "codeSystem": "USDM",
        "decode": "Double Blind"
      },
      "maskedRoles": [
        "Subject",
        "Investigator"
      ],
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "allocationRatio": {
        "ratio": "1:1:1:1"
      },
      "stratificationFactors": [
        "country",
        "sex",
        "prediabetes status"
      ],
      "controlType": {
        "code": "Placebo Control",
        "codeSystem": "USDM",
        "decode": "Placebo Control"
      },
      "armIds": [
        "arm_1",
        "arm_2",
        "arm_3",
        "arm_4"
      ],
      "cohortIds": [
        "cohort_1",
        "cohort_2"
      ],
      "therapeuticAreas": [
        "Obesity",
        "Metabolic Disorders"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment"
      ],
      "blinding": {
        "schema": "Double Blind",
        "maskedRoles": [
          "Subject",
          "Investigator"
        ]
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": "1:1:1:1",
        "stratificationFactors": [
          "country",
          "sex",
          "prediabetes status"
        ]
      },
      "controlType": "Placebo",
      "therapeuticAreas": [
        "Obesity",
        "Metabolic Disorders"
      ]
    },
    "arms": [
      {
        "name": "Tirzepatide 5 mg",
        "type": "Experimental Arm",
        "description": "Participants receive tirzepatide 5 mg once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      },
      {
        "name": "Tirzepatide 10 mg",
        "type": "Experimental Arm",
        "description": "Participants receive tirzepatide 10 mg once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      },
      {
        "name": "Tirzepatide 15 mg",
        "type": "Experimental Arm",
        "description": "Participants receive tirzepatide 15 mg once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      },
      {
        "name": "Placebo",
        "type": "Placebo Comparator",
        "description": "Participants receive placebo once weekly by subcutaneous injection in conjunction with reduced-calorie diet and increased physical activity"
      }
    ],
    "cohorts": [
      {
        "name": "Participants without prediabetes",
        "characteristic": "Participants without prediabetes at randomization who complete 72 weeks of treatment"
      },
      {
        "name": "Participants with prediabetes",
        "characteristic": "Participants with prediabetes at randomization who continue for additional 104 weeks (total 176 weeks) to assess progression to T2DM"
      }
    ],
    "epochs": [
      {
        "name": "Screening",
        "description": "2-week screening period"
      },
      {
        "name": "Dose Escalation",
        "description": "20-week dose escalation period within treatment"
      },
      {
        "name": "Treatment Period (Primary)",
        "description": "72-week treatment period for all participants"
      },
      {
        "name": "Additional Treatment Period",
        "description": "Additional 104-week treatment period for participants with prediabetes at randomization (total 176 weeks)"
      },
      {
        "name": "Safety Follow-up",
        "description": "4 weeks for those completing within first 72 weeks; 17 weeks for those completing after Week 72"
      }
    ]
  }
}